Company Data
Pharvaris N.V.
Ticker
PHVS
Current Price
$22.84 -3.95%
Market Cap
$1.2B
Price Target
Refer to Report
Volume
43.6K
52wk Range
$11.51 - $26.33
Overview
Pharvaris NV is a clinical-stage company. It is focused on the discovery and development of novel oral bradykinin B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications.